HHealth Read More New integrated framework advances precision surgery for liver cancerSeptember 9, 2026 Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally. Despite…
TTechnology Read More Combination therapy overcomes ferroptosis resistance in β-catenin-mutant hepatocellular carcinomaAugust 8, 2026 Background and aims The aberrant activation of the mTOR pathway and its crosstalk with other signaling cascades represent…
HHealth Read More Daily tomatoes lowered a key marker of liver fat in MASLD trialAugust 3, 2026 A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
HHealth Read More Occult hepatitis B mutations drive liver cancer growth via Akt mTOR pathwayJuly 23, 2026 Occult hepatitis B virus (OBI) infection presents a significant global health challenge, notoriously flying under the radar of…
TTechnology Read More Integrating gene signatures and multi omics improves liver cancer treatmentJuly 14, 2026 Hepatocellular carcinoma (HCC) remains highly fatal due to late diagnosis and scarce early biomarkers. Multi‑omics and liquid biopsy…
HHealth Read More Liver cancer burden rising globally amid shift to metabolic risksApril 15, 2026 Primary liver cancer continues to pose a major global health challenge, ranking as the third leading cause of…
HHealth Read More Machine learning model predicts liver cancer risk with high accuracyMarch 27, 2026 Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test…
HHealth Read More Researchers develop new score to predict the risk of liver cancerFebruary 18, 2026 Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed…
TTechnology Read More University of Missouri launches first on-campus radiopharmaceutical clinical trialFebruary 10, 2026 In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…
HHealth Read More Study identifies key molecular and clinical biomarkers for MASLDSeptember 26, 2025 Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
HHealth Read More Coffee protects the liver by blocking inflammation and scarring, review findsSeptember 22, 2025 Scientists reveal how your daily cup of coffee may guard against liver disease, connecting population trends with the…